A liposomal radionanoformulation for targeted drug delivery and real time monitoring by radionuclide imaging for HER2 overexpressing cancers.

Saved in:
Bibliographic Details
Title: A liposomal radionanoformulation for targeted drug delivery and real time monitoring by radionuclide imaging for HER2 overexpressing cancers.
Authors: Suman SK; Radiopharmaceuticals Division, Bhabha Atomic Research Centre (BARC), Mumbai, India.; Homi Bhabha National Institute, Mumbai, India., Mukherjee A; Radiopharmaceuticals Division, Bhabha Atomic Research Centre (BARC), Mumbai, India.; Homi Bhabha National Institute, Mumbai, India., Sharma RK; Department of Chemistry and Centre of Advanced Studies, Panjab University, Chandigarh, India.
Source: Drug development research [Drug Dev Res] 2023 Nov; Vol. 84 (7), pp. 1553-1563. Date of Electronic Publication: 2023 Aug 14.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 8204468 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1098-2299 (Electronic) Linking ISSN: 02724391 NLM ISO Abbreviation: Drug Dev Res Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1098-2299
DOI:10.1002/ddr.22106